The Williams Companies (WMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEXICO CITY--(BUSINESS WIRE)---- $III #AI--Enterprises in Mexico are accelerating cloud modernization and AI adoption, aided by AWS' establishment of a regional hub in the country, ISG says.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dick's Sporting Goods, Inc. (NYSE: DKS) breached their fiduciary duties to shareholders. If you currently own Dick's stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about you.

VANCOUVER, Wash. & AUSTIN, Texas--(BUSINESS WIRE)-- #Customer--ZoomInfo (NASDAQ: GTM), the Go-To-Market Intelligence Platform, today announced a strategic partnership with Markaaz, the leading global business identity and intelligence platform, to deliver a comprehensive, AI-powered B2B data solution that unifies sales intelligence with credit and risk data—creating the industry's first true end-to-end master data platform for enterprise organizations. The solution will transform how companies identify, ve.

LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Quantum Corporation (“Quantum” or “the Company”) (NASDAQ: QMCO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 15, 2024, and August 18, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 3, 2025.

A Media Snippet accompanying this announcement is available by clicking on this link.

Carbon Measures, a new carbon accounting initiative backed by a number of big energy and multinational companies, will create an independent panel to help guide its work, its chief executive told Reuters.

Eli Lilly's Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure of pricing and competition.

HWM heads into Q3 earnings with solid aerospace momentum but faces valuation pressures and transport market softness.

Unusual Machines, Inc. (UMAC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Symbotic's surging backlog, strong revenue growth and upbeat guidance give it an edge over Futu Holdings in the tech services showdown.

The mean of analysts' price targets for Priority Technology (PRTH) points to a 65.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 42.8% upside potential for Tamboran Resources Corporation (TBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 25.6% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 34.6% in Transcat (TRNS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Shares in the semiconductor maker rise 20% as it launches AI chip to compete with Nvidia.

As U.S. inflation hits 3%, dividend growth stocks like Vertiv, TSM, Oracle, Lam Research, and Elbit Systems shine.